Emer Leahy serves as Executive at Pasithea Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Emer Leahy has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 28, 2025 involved receiving (via award) 33,333 shares valued at $25.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 28, 2025 | KTTA | $25.0K | Award | 33,333 | $0.75 | Discretionary |
Emer Leahy currently holds 33,333 shares of Pasithea Therapeutics Corp. (KTTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Emer Leahy has been a net neutral trader of KTTA stock. They have purchased $0 and sold $0 worth of shares.
Emer Leahy's most recent insider trade was on Nov 28, 2025, when they sold 33,333 shares at $0.75 per share.
Get notified when new Form 4 filings are submitted